Phase II Trial of Organ Preservation Program Using Short-Course Radiation and Folfoxiri for Rectal Cancer (SHORT-FOX): Clinical Response Outcomes.

MLA

Pollom, E., et al. “Phase II Trial of Organ Preservation Program Using Short-Course Radiation and Folfoxiri for Rectal Cancer (SHORT-FOX): Clinical Response Outcomes.” International Journal of Radiation Oncology, Biology, Physics, vol. 120, no. 2, Oct. 2024, p. S116. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2024.07.211.

APA

Pollom, E., Fisher, G. A., Shelton, A., Johnson, T., Chen, C., Jackson, S., Shaheen, S., Holden, T. L., Bien, J. Y. E., King, D., Morris, A., Kin, C., Dawes, A., Kirilcuk, N., Vitzthum, L., Rahimy, E., Sheth, V., Brown, E., Pratapneni, A., & Chang, D. T. (2024). Phase II Trial of Organ Preservation Program Using Short-Course Radiation and Folfoxiri for Rectal Cancer (SHORT-FOX): Clinical Response Outcomes. International Journal of Radiation Oncology, Biology, Physics, 120(2), S116. https://doi.org/10.1016/j.ijrobp.2024.07.211

Chicago

Pollom, E., G.A. Fisher, A. Shelton, T. Johnson, C. Chen, S. Jackson, S. Shaheen, et al. 2024. “Phase II Trial of Organ Preservation Program Using Short-Course Radiation and Folfoxiri for Rectal Cancer (SHORT-FOX): Clinical Response Outcomes.” International Journal of Radiation Oncology, Biology, Physics 120 (2): S116. doi:10.1016/j.ijrobp.2024.07.211.